Triazolylthioacetamide: A Valid Scaffold for the Development of New Delhi Metallo-β-Lactmase-1 (NDM-1) Inhibitors
Triazolylthioacetamide: A Valid Scaffold for the Development of New Delhi Metallo-β-Lactmase-1 (NDM-1) Inhibitors
复制标题
三唑基硫代乙酰胺:开发新德里 Metallo-beta-Lactmase-1 (NDM-1) 抑制剂的有效支架
DOI:
10.1021/acsmedchemlett.5b00495
复制
发表时间:
2016-04-01
影响因子:
4.2
通讯作者:
Yang, Ke-Wu
中科院分区:
文献类型:
--
作者:
Zhai, Le;Zhang, Yi-Lin;Yang, Ke-Wu
The metallo-beta-lactamases (M beta Ls) cleave the beta-lactam ring of beta-lactam antibiotics, conferring resistance against these drugs to bacteria. Twenty-four triazolylthioacetamides were prepared and evaluated as inhibitors of representatives of the three subclasses of M beta Ls. All these compounds exhibited specific inhibitory activity against NDM-1 with an IC50 value range of 0.15-1.90 mu M, but no activity against CcrA, ImiS, and L1 at inhibitor concentrations of up to 10 mu M. Compounds 4d and 6c are partially mixed inhibitors with K-i values of 0.49 and 0.63 mu M using cefazolin as the substrate. Structure activity relationship studies reveal that replacement of hydrogen on the aromatic ring by chlorine, heteroatoms, or alkyl groups can affect bioactivity, while leaving the aromatic ring of the triazolylthiols unmodified maintains the inhibitory potency. Docking studies reveal that the typical potent inhibitors of NDM-1, 4d and 6c, form stable interactions in the active site of NDM-1, with the triazole bridging Zn1 and Zn2, and the amide interacting with Lys 211 (Lys224).